参考文献/References:
[1] Mora-Fernandez C,Dominguez-Pimentel V,de Fuentes MM,etal.Diabetic kidney disease: from physiology to therapeutics[J].J Physiology,2014,592(Pt 18):3997-4012.
[2] Yang L,Ma J,Zhang X,et al.Protective role of the vitamin D receptor[J].Cell Immunol,2012,279(2):160-166.
[3] Molitch M,De Fronzo RA,Franz MJ,et al.Nephropathy in diabetes[J].Diabetes Care,2004,27(Suppl 1):S79-83.
[4] Bendik I,Friedel A,Roos FF,et al.Vitamin D:a critical and essential micronutrient for human health[J].Front Physiol,2014(5):248.
[5] Li YC.Podocytes as target of vitamin D[J].Curr Diabetes Rev,2011,7(1):35-40.
[6] Fernandez-Juarez G,Luno J,Barrio V,et al.25(OH)vitamin D levelsand renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system[J].Clinical Journal of the AmericanSociety of Nephrology,2013,8(11):1870-1876.
[7] Santoro D,Caccamo D,Lucisano S,et al.Interplay of vitamin D,erythropoiesis,and the reninangiotensin system[J].Biomed Res Int,2015(2015):145828.
[8] 毛达勇,喻 飞,张吉才.糖尿病肾病患者铁代谢的研究[J].现代检验医学杂志,2011,26(4):105-107.
Mao DY,Yu F,Zhang JC.Study of iron metabolism in diabetic nephropathy patients[J].Journal of Modern Laboratory Medicine,2011,26(4):105-107.
[9] 兰 飞.尿转铁蛋白和胱抑素C联合检测在原发性肾小球肾炎患者早期诊断的应用[J].检验医学与临床,2014,11(2):234-235.
Lan F.The application of urinary transferrin and Cystatin C joint detection in early diagnosis of primary glomerular nephritis[J].Laboratory Medicine and Clinic,2014,11(2):234-235.
[10] Holzscheiter L,Beck C,Rutz S,et al.NGAL,L-FABP,and KIM-1 in comparison to established markers of renal dysfunction[J].Clin Chem Lab Med,2014,52(4):537-546.